3 Stocks Coming With Bonus Shares In 1:1, 2:1 & 5:2 Ratio: Check Details From Record Date To Target Price

Pro Fin Capital Services, Thyrocare Technologies Limited, and Panorama Studios International are the three companies that recently announced bonus shares. Because these offerings have attractive ratios-1:1, 2:1, and 5:2-it is essential for savvy market participants to take into account each company's details, carefully verifying the record dates to confirm eligibility and analyzing market opinions regarding possible target prices to make well-informed investment decisions.

Panorama Studios International Bonus Shares

"The Board has considered and recommended the issue of Bonus Shares in the ratio of 5:2 i.e., 5 (Five) new fully paid-up Equity Shares of Rs 2/- each for every 2 (Two) existing fully paid-up Equity Shares of Rs 2/- each, held by the eligible Equity Shareholders of the Company as on the Record Date to be determined for this purpose. Accordingly, the Company will issue and allot 18,60,96,875 (Eighteen Crore Sixty Lakh NinetySix Thousand Eight Hundred Seventy-Five) Equity Shares of Rs 2/- each as Bonus Shares, by capitalizing free reserves, including the Securities Premium Account and/or General Reserve, as may be approved by the shareholders at the forthcoming Extra-Ordinary General Meeting (EGM) of the Company. Accordingly, the Company will issue and allot 18,60,96,875 (Eighteen Crore Sixty Lakh NinetySix Thousand Eight Hundred Seventy-Five) Equity Shares of Rs 2/- each as Bonus Shares, by capitalizing free reserves, including the Securities Premium Account and/or General Reserve, as may be approved by the shareholders at the forthcoming Extra-Ordinary General Meeting (EGM) of the Company," said the company in a stock exchange filing on 15th October.

As bonus shares, the corporation is considering issuing 18,60,96,875 fully paid-up equity shares with a face value of Rs 2. The company's paid-up share capital was Rs 14,88,77,500 before the bonus issue, which included 7,44,38,750 shares. After the bonus issue, it will rise to Rs 52,10,71,250, which includes 26,05,35,625 shares.

The bonus issue is expected to need Rs 37,21,93,750 in free reserves and/or share premium. In order to provide sufficient reserves for the capitalization to execute the bonus issue, the company reported a Securities Premium balance of Rs 46,66,20,750 as of March 31, 2025, and Retained Earnings of Rs 1,24,20,43,916.

Within 60 days from the date of the Board Meeting i.e. on or before December 14, 2025, the company is expecting to credit the bonus shares to the eligible shareholders.

Panorama Studios International Target Price

"Panorama Studios stock price is bearish on the Daily charts with strong resistance at 210. A Daily close below support of 190 could lead to a target of 172 in the near term," said A R Ramachandran, Independent SEBI registered Research Analyst.

Pro Fin Capital Services Bonus Shares

"Pursuant to regulation 30 & 33 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. October 10, 2025, commenced at 05.00 PM and concluded at 06.30 P.M, has considered and approved the issue of Bonus Shares in the ratio of 1:1," said Pro Fin Capital Services in a stock exchange filing.

Pro Fin Capital Services Target Price

"Pro Fin Capital stock price is bearish on the Daily charts with strong resistance at 11.51. A Daily close below support of 10.45 could lead to a target of 9 in the near term," recommended A R Ramachandran.

Thyrocare Technologies

"The Company is celebrating its Silver Jubilee this year, marking the completion of 25 years since its incorporation and, in line with the forthcoming auspicious celebrations of Diwali, the Board has approved and recommended a Bonus Issue as a gesture of appreciation to its shareholders for their continued trust and support. The Board has considered, approved, and recommended the issuance of Bonus Shares in the ratio of 2:1, i.e., 2 (Two) fully paid-up Equity Shares of face value of Rs. 10/- (Rupees Ten Only) each for every 1 (One) existing fully paid-up Equity Share of face value of Rs. 10/- (Rupees Ten Only) held by the eligible Equity Shareholders of the Company as on the record date, by capitalization of Capital Redemption Reserve and/or Securities Premium and/or General Reserve and/or Retained Earnings of the Company, subject to the approval of the Shareholders of the Company and other regulatory approvals, as may be required. The Company will notify the record date for determining the eligibility of shareholders entitled to receive the Bonus Shares in due course," said Thyrocare Technologies in a regulatory filing on October 14.

As part of its bonus share issue, Thyrocare Technologies Limited has announced the issuing of 10,61,07,794 bonus equity shares at a price of Rs 10. Capitalizing funds from the Capital Redemption Reserve, Securities Premium Account, Free Reserves, and/or Retained Earnings as of September 30, 2025, shall be used to pay out these bonus shares.

In order to reflect the increased share base, the company's authorized share capital will increase from Rs 1,00,00,00,000, which consists of 10 crore shares of Rs 10 each, to Rs 3,00,00,00,000, which consists of 30 crore shares of Rs 10 each, following the bonus issue. Additionally, the issued, subscribed, and paid-up capital will increase from Rs 53,05,38,970, which consists of 5,30,53,897 shares.

The total issued, subscribed, and paid-up capital of Thyrocare Technologies Limited as on October 14, 2025, was Rs 159.16 crore, which is divided among 15,91,61,691 equity shares valued at Rs 10 apiece. The company believes that about Rs 106.11 crore from its reserves and surplus would be needed to effectuate the proposed 2:1 bonus share issuance.

A Capital Redemption Reserve of Rs 0.96 crore, Securities Premium of Rs 78.09 crore, General Reserve of Rs 205.42 crore, and Retained Earnings of Rs 76.29 crore comprise the unaudited reserves position as of September 30, 2025.

The bonus equity shares are anticipated to be credited within two months of the board approval date, or by December 13, 2025, at the latest, after receiving the necessary authorizations.

The total number of shares may further vary based on stock option exercises under the Thyrocare Employee Stock Option Scheme before the record date.

Thyrocare Technologies Target Price

"Thyrocare stock price is bearish on the Daily charts with strong resistance at 1474. A Daily close below support of 1206 could lead to a target of 1091 in the near term," recommended A R Ramachandran, Independent SEBI registered Research Analyst.

Disclaimer

The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.